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Abstract We have cloned earlier a short human genomic
fragment which showed strong similarity with the mouse cDNA
encoding lung Kruppel-like zinc finger transcription factor
(LKLF), predominantly expressed in mouse developing lung,
spleen, and vascular system, which might play a key role in
programming the quiescent state of single positive T cells and
blood vessel wall morphogenesis. Here we report the successful
cloning of the human LKLF cDNA, its genomic structure and
chromosomal localization at the 19p13.11^p13.13 locus. The full-
length human LKLF cDNA has longer 5P-UTR with higher GC
content than mouse cDNA and encodes a predicted protein of 355
amino acids which has three zinc fingers at the C-terminus and a
proline-rich N-terminal domain. Human and mouse proteins
share 87.3% identity and 90.2% amino acid similarity. The
human LKLF gene consists of three exons. From the proximal
promoter to the end of the second exon, we have found a CpG
island with an average 76% GC content and two regions of
unusually high GC density.
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1. Introduction
Eukaryotic transcription factors containing Cys2-His2-type
(Kruppel-like) zinc ¢ngers are involved in various processes of
cell growth and di¡erentiation and many of these factors ex-
hibit highly restricted patterns of expression in tissues and
during development [1^3]. These factors share a common
principle of structural organization. While zinc ¢nger domains
have a conservative structure, the activation domains di¡er
signi¢cantly and often contain regions rich in proline, gluta-
mine, and dicarbonic amino acids [4,5]. Recently, some new
proteins of this family have been identi¢ed: EKLF [6], BKLF
[7], LKLF [8] and GKLF [9]. It was demonstrated that mouse
lung Kruppel-like factor (LKLF) is expressed in the lung, the
developing vascular system, heart, skeletal muscles, kidney,
testis and in lymphoid tissues [1,2]. After examination of dif-
ferent cells, LKLF expression was revealed in mature SP thy-
mocytes and splenocytes, B220+/IgM+ splenic B cells and in
bone marrow macrophages [1]. Interestingly, LKLF was ex-
pressed only in mature resting T cells down-regulated imme-
diately after their activation [1,10]. LKLF-de¢cient T cells
produced by gene targeting were very susceptible to Fas-medi-
ated apoptosis because of the rapidly increasing level of Fas
ligand expression [1]. The Fas ligand belonging to the tumor
necrosis factor family is known to be expressed in activated T
cells and induces apoptosis when it binds to its receptor Fas.
Thus it may be suggested that LKLF might play a key role in
establishing the quiescent state of T cells by preventing spon-
taneous activation and subsequent apoptosis of these immune
cells [1]. LKLF also appeared to take place in regulating
blood vessel wall morphogenesis as it was found that LKLF
is expressed in vascular endothelial cells throughout mouse
embryogenesis [2,11].
Earlier, during the total human genome NotI mapping proj-
ect we cloned a short NotI jumping clone, which is part of the
CpG island and displays similarity with mouse LKLF cDNA
[12]. In this study we report the cloning of the human LKLF
cDNA, its gene structure and chromosomal mapping.
2. Materials and methods
2.1. Cloning of human LKLF cDNA
5P-RACE PCR and 3P-RACE PCR were applied to isolate cDNA
of the human LKLF gene. The plasmid clone jl003 containing a 111-
bp NotI human genomic fragment obtained as described [12] was used
for the design of two sets of the gene-speci¢c PCR primers: RN-1 (5P-
GGCCTCCAGCAGCTCCAGCGGGG-3P), and nested RN-2 (5P-G-
CAGGCGGCGTGAGGAGACC-3P), and DN-1 (5P-CGCGGTCTC-
CTCACGCCG-3P), and nested primer DN-2 (5P-CCCCGCTGGAG-
CTGCTGGAGGCC-3P). Ap1 and Ap2 primers were provided in the
Marathon-Ready cDNA kit purchased from Clontech Laboratories.
The human lung adaptor-ligated Marathon-Ready cDNA was used as
a template for PCR: 30 cycles of denaturation at 95‡C for 20 s,
annealing at 64‡C for 20 s, polymerization at 72‡C for 1.5 min in
the bu¡er containing 50 mM Tris-HCl, pH 9.2, 16 mM ammonium
sulfate, 1.75 mM MgCl2, 0.2 mM of each dNTP, 0.5 U of Taq poly-
merase, 5% DMSO and 1 M betaine for 5P-RACE and for 3P-RACE
in the same bu¡er with 5% DMSO only. After the ¢rst round of PCR
nested PCR was carried out in the same conditions.
2.2. Genomic structure analysis
Exon-intron boundaries were determined by using PCR with K-1
(5P-CCCATCCTGCCGTCCTTTTCCACTTTCG-3P) and RN-3 (5P-
CCGGGACCTCGCATGCA-3P) primers for the ¢rst intron and
DN-2 and RN (5P-CTGTGCCCGGCCCGGTTCTCT-3P) primers
for the second intron. To clone the 5P-upstream region we carried
out inverse PCR as described [13]. Brie£y, genomic DNA was com-
pletely digested with BamHI restriction endonuclease and self-ligated
at 1.5 Wg/ml of DNA concentration. Primary PCR was performed
with 4.5 ng of self-ligated genomic DNA and RN-3 and DN-2 primers
at the conditions described above for cDNA cloning. Then, 1/50 part
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of the diluted primary PCR product was used as a template for sec-
ondary PCR with RN-5 (5P-CGACAGGGCAATGGGCG-3P) and
I-2d (5P-CCTTGGGGCGTGGCTCA-3P) primers.
2.3. Sequence analysis
All PCR products were puri¢ed from 1% low-melting-point agarose
gel, cloned into pUC 19 via blunt ends and sequenced on an auto-
mated DNA sequencer (Applied Biosystems) with ABI Prism Dye
Terminator Cycle Sequencing Ready Reaction kit from Perkin-Elmer.
Computational analysis and nucleotide sequence homology searches
were performed using the BLAST program at http://www.ncbi.nlm.
nih.gov/BLAST/, TFSEARCH program at http://www.genome.ad.jp/
SIT/TFSEARCH.html and TESS program at http://agave.humgen.
upenn.edu/utess/tess?request=SBS-FRMREQ-BasicQuery and DNA-
SIS software from Hitachi Software Engineering. Protein alignment
was done with ClustalX program. The GenBank accession number for
the human LKLF gene is AF123344.
2.4. Chromosomal mapping of the human LKLF gene
A Genebridge 4 radiation hybrid panel obtained from Research
Genetics (Huntsville, AL, USA) consisting of 93 radiation hybrid
clones, one human cell clone and a hamster recipient cell clone was
used. Three independent PCR ampli¢cations were performed on the
panel samples and controls, and the products were analysed in a 2%
agarose gel. A 313-bp fragment was obtained by PCR ampli¢cation
with the primers M-1 (5P-TGACAACAGTGGGGAGTGG-3P) and
M-2 (5P-GTGTGCTTTCGGTAGTGG-3P). The PCR ampli¢cation
conditions were: 20 pmol of each primer, 1UPCR bu¡er (supplied
with the enzyme, Boehringer Mannheim), 6% DMSO, 1 M betaine, 25
ng of DNA and H2O to a ¢nal volume of 8.9 Wl, and incubated at
99‡C for 10 min. The samples were immediately placed on ice and
0.25 mM dNTP and 0.5 U of Taq polymerase (Boehringer Mann-
heim) were added. 37 cycles were performed consisting of 94‡C
2 min, 67‡C 30 s and 72‡C 1 min, 1 cycle; and 94‡C 45 s, 67‡C 30 s
and 72‡C 1 min for 35 cycles followed by extension for 10 min. The
PCR results were sent to the Whitehead Institute/MIT Center for
Genome Research at the http://www.genome.wi.mit.edu for estab-
lishing the localization of the human LKLF gene and the found
location data were compared with the Marshmed genetic map
(http://www.marshmed.org/), Genetic Location Database (LDB)
(http://cedar.genetics.soton.ac.uk/public_html/) and Genome Data-
base (GDB) (http://www.gdb.org).
3. Results and discussion
3.1. Cloning and sequencing of the human LKLF cDNA
To clone human LKLF cDNA, we used information from
the previously characterized NotI jumping clone jl003, which
we obtained during the total NotI human genome mapping
project [12,14]. The size of the DNA insert in this clone was
111 bp, of which 92 bp were G/C. To overcome the di⁄culties
caused by high GC content during PCR we used 1 M betaine
and 5% DMSO known to be e⁄cient in melting GC-rich
regions [15,16]. Two rounds of 5P- and 3P-RACE PCR on
the human lung Marathon-Ready cDNA template with the
gene-speci¢c primers based on the sequence from the jl003
clone and the adaptor primer Ap1 and the nested adaptor
primer Ap2 resulted in the isolation of LKLF cDNA frag-
ments. Analysis of the products by 1% agarose gel electro-
phoresis revealed that the 5P-RACE PCR product, unlike
the 3P-RACE PCR product, was non-homogeneous even after
nested PCR (Fig. 1A). We have found that about half of the
cloned and sequenced 5P-RACE PCR fragments contained the
entire sequence of the ¢rst intron at the 5P end instead of the
¢rst exon sequence (Fig. 1B), but we could not uncover the
presence of the second intron sequence in the cDNA template.
Marathon-Ready cDNA appears to contain partially spliced
cDNA sequences.
The length of the longest cDNA obtained after 5P-RACE
and 3P-RACE PCR was 1671 bp. Many human expressed
sequence tags (EST) were found after a search in the Gen-
Bank (release of 16 September 1998), which represent di¡erent
short sequences located between the second NotI site and the
3P-UTR. The 5P-UTR is longer and has higher GC content
than in mouse cDNA (GenBank U25096).
3.2. The deduced amino acid sequence of human LKLF
The entire human LKLF cDNA encodes a 355-amino acid
protein with a calculated molecular mass of 37.4 kDa and an
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Fig. 1. Human LKLF cDNA PCR ampli¢cation. A: 5P- and 3P-
RACE PCR fragments of human LKLF cDNA. 3P-RACE PCR
products ampli¢ed with primer sets DN-1/Ap1 for the primary PCR
(lane 1) and Dn-2/Ap2 for the secondary PCR (lane 2). 5P-RACE
PCR products using primer pair RN-1/Ap1 (lane 3) and nested pri-
mer pair Rn-2/Ap2 (lane 4). B: Ampli¢cation products generated
from the Marathon-Ready cDNA using exon-speci¢c primers K-1
and Rn-3 (lane 1) and intron-speci¢c primer Rn-5 and adaptor pri-
mer Ap2 (lane 2). Lane M (A and B): DNA size marker.
Fig. 2. Alignment of the human and mouse LKLF protein sequences. Amino acids are shown in standard one-letter code. Dots represent iden-
tical amino acids, dashes indicate gaps. The three zinc ¢ngers are boxed. Proline residues, alanine stretch and nuclear localization signal are in
bold letters.
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estimated pI of 8.8. The protein is rich in proline residues
which constitute 17.5% of the total amino acids and form
Pro-rich repeats of three to eight amino acids in a row. An
additional feature of the human LKLF is an alanine stretch at
the border between the putative activation domain and the
zinc ¢nger domain (Fig. 2). We also revealed a 16-amino
acid stretch adjacent to the ¢rst zinc ¢nger sequence
KPKRGRRSWPRKRTAT which should be considered a po-
tential nuclear localization signal [17]. This sequence is iden-
tical in human LKLF and mouse gut-enriched Kruppel-like
factor (GKLF) [9]. The three zinc ¢ngers are similar to the
zinc ¢nger consensus sequence Cys-X2ÿ4-Cys-X12-His-X3ÿ4-
His [18] while only the ¢rst inter-¢nger spacer, the so-called
H/C link, consisting of seven amino acids, has the conserva-
tive sequence TGEKPYH. Thus, the human protein has a
canonical Kruppel-like transcription factor structure and is
divided into two domains, the Pro-rich transactivating N-ter-
minal domain and the C-terminal zinc ¢nger containing do-
main. Human and mouse proteins share 87.3% identity and
90.2% amino acid similarity (Fig. 2).
3.3. Gene structure analysis
The genomic organization was determined by applying
standard PCR for identifying exon-intron boundaries and
by inverse PCR for cloning the 5P-£anking region. The human
LKLF gene spans over 3 kb and is composed of three exons
having sizes of 174 bp, 817 bp and 680 bp, interrupted by two
introns (Fig. 3). Both introns show classical GT/AG sequences
£anking the splice junctions [19] and are 217 bp and 819 bp in
size. The splice site for the ¢rst intron occurs between the 25th
and 26th amino acid codons. The second intron disrupts the
glycine codon GGT located within the ¢rst H/C link.
Although the 5P-£anking region of the gene manifests typ-
ical features of GC-rich promoter with multiple transcription
factor Sp1 binding sites, it nevertheless contains two putative
TATA box consensus motifs as revealed by database analysis
using the TFSEARCH and TESS programs. It is unclear yet
whether these elements are functionally active.
As one can see from the plot of CpG and GpC distribution
(Fig. 3), the human LKLF gene contains a CpG island where
76% of the nucleotides are either C or G. This CGI is about
1.6 kb and spans from the promoter region to the end of the
second exon. Interestingly, inside the CGI body regions of the
proximal promoter and the central part of the second exon
have as much as 80% and 82% GC, respectively. The presence
of these two regions separated by the intron with lower CpG/
GpC density could be the consequence of a mutational proc-
ess which does not a¡ect the functionally essential regions.
Promoter regions in the mammalian genes are often protected
from the action of DNA methyltransferase by DNA binding
transcription factors and contain unmethylated CpG dinu-
cleotides. Many of other CpGs scattered throughout the ge-
nome are methylated during the cell cycle and are prone to
mutate to TpG or CpA [20]. The sequence of the second GC-
rich region encodes CG-containing proline codons in the
transactivation domain and therefore could also be protected
from the mutational changes. As was shown earlier [21], many
of the zinc ¢nger proteins encoding genes encompass CpG
islands. Moreover, part of these genes involved in cell growth
and di¡erentiation have clustered NotI sites, which can serve
as CGI markers due to their recognition site GCGGCCGC
and thus facilitate gene cloning and mapping [12].
3.4. Chromosomal localization of the human LKLF gene
Chromosomal localization of the human LKLF gene was
ascertained by PCR ampli¢cation using a Genebridge 4 radi-
ation somatic cell hybrid panel. Results obtained during PCR
were sent to the WICGR mapping service which placed the
human LKLF gene 10.9 cR from the distal marker WI-6344/
D19S825 on 19p13.13 with a LOD score of 19 (Fig. 4). Ac-
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Fig. 3. Genomic organization of the human LKLF gene. Exons (e1, e2, e3) are shown as boxes separated by intronic sequences (i1, i2). Zinc
¢nger region is shaded. The letters B, N, S and D indicate the restriction sites for BamHI, NotI, SacI and DraI, respectively. The jl003 NotI
clone and PCR primers are shown above and below the gene structure. A map plot of CpG and GpC distribution through the gene is repre-
sented by the short vertical lines. CpG island and two regions of encreased CpG/GpC density are marked by horizontal brackets.
Fig. 4. Chromosomal mapping of the human LKLF gene. The re-
sults from three di¡erent maps are compared.
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cording to the Marshmed genetic map and the Genetic Loca-
tion Database (LDB) the human LKLF gene was placed be-
tween D19S588 and D19S410 markers, which cover a region
of 3.2 cM. The distal marker D19S588 has been assigned to
19p13.13 according to LDB and the proximal marker
D19S410 to 19p13.11 via Genome Database (GDB) which
locates LKLF gene within 19p13.11^13.
Interestingly, there are a number of zinc ¢nger genes
mapped on human chromosome 19 [22]. Moreover for some
zinc ¢nger genes in cytogenetic band 19p12 a head-to-tail
arrangement was demonstrated [23]. The human erythroid
Kruppel-like factor (EKLF) gene was reported [24] to map
in 19p13.12^p13.13, the same locus where the human LKLF
gene is located as shown above. Both genes encode the tran-
scription factors belonging to the Kruppel family and their
expression is developmentally regulated in a tissue-speci¢c
fashion [6,8]. The co-localization of these genes and similar
patterns of expression in mouse blood cells pose the question
of whether these genes form not only a structural but also a
functional cluster with possible common regulation.
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